Partnering Solutions
-
Late Stage Customization
2/7/2024
Learn about the benefits of a Late Stage Customization approach, including how it can support a leaner, more responsive supply chain, ensuring life-changing therapies reach patients more efficiently.
-
Decentralized Trials For Small & Mid-Sized Biotechs
4/28/2021
We understand how challenging it is to adopt a novel approach to drug development. Pivoting to virtual clinical trials is no exception.
-
Orphan Drug Designations
10/30/2023
Get unique insights into current expectations set by the U.S. Food and Drug Administration and the European Union, as well as distinctions between Orphan Drug Designation (ODD) criteria for the two entities.
-
Gene Therapy Ready Site Network
4/5/2022
Join more than 1,000 research sites who use Advarra as their IBC of record. Is your research site ready to take advantage of this growing area of clinical trials?
-
ConneX
2/25/2019
ConneX is a global travel solution providing in-market services and support, designed to meet the unique travel needs of each study, whether it be for rare disease, diverse populations, pediatrics, etc. Our offering removes the burden of complex travel arrangement from site staff, while peace of mind is established for participants, their families and caregivers.
-
Solutions For Sites And Institutions
5/17/2023
Streamline workflows across all types of sites, including academic medical centers and commercial sites of varying sizes, with Advarra’s complete suite of independent oversight committees.
-
Liver Disease CRO Services
6/27/2023
Biotechnology companies consider locations in the Asia-Pacific region, such as South Korea and China to access vast treatment-naïve patient populations and accelerate their clinical trials at lower costs.
-
Full-Service Clinical Development Solutions
9/27/2023
Getting a novel therapy through the clinical development process to approval is complicated. Unearth how to advance novel medical therapies from Phase I-III clinical development to market with confidence.
-
eClinicalGPS – Flexible Delivery Model
6/13/2018
Clinical trial financial technology available in three unique delivery models.
-
Advancing Development And Approval Of Rare/Ultra-Rare Disease Therapies
5/8/2024
VeriStat empowers rare disease therapy with science-driven strategies and trusted expertise, supporting over 350 rare disease projects and preparing 40+ marketing applications in the past 5 years.